Standard dose enteric-coated mycophenolate sodium (myfortic) delivers rapid therapeutic mycophenolic acid exposure in kidney transplant recipients

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 861-863

  Sumethkul, V ^a   Na Bangchang, K ^b   Kantachuvesiri, S ^a   Jirasiritham, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG COATING; DRUG DELIVERY SYSTEM; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 17844410117     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.01.007     Document Type: Conference Paper

References (7)

1. A.O. Ojo, H.U. Meier-Kriesche, J.A. Hanson Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection Transplantation 69 2000 2405
2. D.K. Granger Enteric coated mycophenolate sodium: results of two pivotal global multicenter trials Transplant Proc 33 2001 8241
3. K. Budde, P. Glander, F. Diekmann Expert Opin Pharmacother 5 2004 333
4. K. Na-Bangchang, O. Supasyndh, T. Supaporn Simple and sensitive high-performance liquid chromatographic Chromatogr B Biomed Sci Appl 738 2000 69
5. L.M. Shaw, D.W. Holt, M. Oellerich Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion Ther Drug Monit 23 2001 305
6. M.D. Hale, A.J. Nicholls, R.E. Bullingham The pharmacokinetic- pharmacodynamic relationship for mycophenolate mofetil in renal transplantation Clin Pharmacol Ther 64 1998 672
7. S. Gabardi, J.L. Tran, M.R. Clarkson Enteric coated mycophenolate sodium Ann Pharmacother 37 2003 1685